UFP Technologies Inc (UFPT)
219.51
+1.77
(+0.81%)
USD |
NASDAQ |
Apr 19, 10:42
UFP Technologies Total Return Price: 219.51 for April 19, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 18, 2024 | 217.74 |
April 17, 2024 | 225.63 |
April 16, 2024 | 227.00 |
April 15, 2024 | 228.74 |
April 12, 2024 | 228.99 |
April 11, 2024 | 227.86 |
April 10, 2024 | 236.93 |
April 09, 2024 | 248.85 |
April 08, 2024 | 253.27 |
April 05, 2024 | 251.35 |
April 04, 2024 | 250.20 |
April 03, 2024 | 248.24 |
April 02, 2024 | 247.59 |
April 01, 2024 | 250.83 |
March 28, 2024 | 252.20 |
March 27, 2024 | 252.15 |
March 26, 2024 | 240.62 |
March 25, 2024 | 236.09 |
March 22, 2024 | 244.60 |
March 21, 2024 | 237.41 |
March 20, 2024 | 225.96 |
March 19, 2024 | 214.39 |
March 18, 2024 | 193.87 |
March 15, 2024 | 193.40 |
March 14, 2024 | 192.04 |
Date | Value |
---|---|
March 13, 2024 | 195.57 |
March 12, 2024 | 195.26 |
March 11, 2024 | 193.37 |
March 08, 2024 | 199.95 |
March 07, 2024 | 206.48 |
March 06, 2024 | 207.26 |
March 05, 2024 | 204.29 |
March 04, 2024 | 215.82 |
March 01, 2024 | 216.80 |
February 29, 2024 | 208.31 |
February 28, 2024 | 208.26 |
February 27, 2024 | 205.93 |
February 26, 2024 | 215.62 |
February 23, 2024 | 210.58 |
February 22, 2024 | 214.09 |
February 21, 2024 | 210.19 |
February 20, 2024 | 193.81 |
February 16, 2024 | 193.28 |
February 15, 2024 | 198.00 |
February 14, 2024 | 185.18 |
February 13, 2024 | 172.63 |
February 12, 2024 | 176.78 |
February 09, 2024 | 174.72 |
February 08, 2024 | 172.79 |
February 07, 2024 | 170.66 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
31.23
Minimum
Mar 18 2020
253.27
Maximum
Apr 08 2024
85.31
Average
64.63
Median
Dec 01 2021
Total Return Price Benchmarks
Integer Holdings Corp | 117.02 |
ICU Medical Inc | 98.54 |
LeMaitre Vascular Inc | 63.12 |
ResMed Inc | 179.27 |
Perspective Therapeutics Inc | 1.47 |